Cover image not available

Costing statement : Ustekinumab for the treatment of adults with moderate to severe psoriasis

National Institute for Health and Clinical Excellence

Publication Data

Title Costing statement : Ustekinumab for the treatment of adults with moderate to severe psoriasis
Alternative Title Ustekinumab for the treatment of adults with moderate to severe psoriasis
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 0000
Publication location London

Topics

Psoriasis :: Chemotherapy :: Cost effectiveness
England

Catalogue Data

OBNB ID GBB586649
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.526061

ISBD

P1053 1 online resource (4 pages)
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Costing statement : Ustekinumab for the treatment of adults with moderate to severe psoriasis by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence. Publication and catalogue information, links to buy online and reader comments.